首页> 外文期刊>Toxicology Research >Cell to rodent: toxicological profiling of folate grafted thiomer enveloped nanoliposomes
【24h】

Cell to rodent: toxicological profiling of folate grafted thiomer enveloped nanoliposomes

机译:啮齿动物的细胞:叶酸接枝噻吩的毒理学仿形包膜纳米脂质体

获取原文
获取原文并翻译 | 示例
           

摘要

Polymeric nanomaterials, hybridized with lipid components, e.g. phosphocholine or fatty acids, are currently being explored for efficient nano-platforms for hydrophobic drugs. However, their toxicology and toxicokinetics need to be established before enabling their clinical potential. The aim of this study was to investigate the toxicological profile of thiomer enveloped hybrid nanoliposomes (ENLs) and bare nanoliposomes (NLs), loaded with docetaxel (DTX) hydrophobic drug, biocompatible nano-carriers for therapeutic cargo. The in vitro toxicity of hybrid ENLs and NLs was evaluated towards the HCT-116 colon cancer cell line. Biocompatibility was explored against macrophages and acute oral toxicity was examined in mice for 14 days. The anticancer IC50 for ENLs was 0.148 mu g ml(-1) compared with 2.38 mu g ml(-1) for pure docetaxel (DTX). The human macrophage viability remained above 65% and demonstrated a high level of biocompatibility and safety of ENLs. In vivo acute oral toxicity showed slight changes in serum biochemistry and haematology but no significant toxicities were observed referring to the safety of DTX loaded hybrid ENLs. On histological examination, no lesions were determined on the liver, heart and kidney. These studies showed that hybrid ENLs can serve as a safe and biocompatible platform for oral delivery of hydrophobic drugs.
机译:聚合物纳米材料,用脂质组分杂交,例如脂质组分。目前正在探索磷化胆碱或脂肪酸,用于疏水药物的有效纳米平台。然而,在实现临床潜力之前,需要建立它们的毒理学和毒性学。本研究的目的是研究巯基包膜杂交纳米脂质(ENL)和裸纳米骨髓(NLS)的毒理学曲线,其加载加入多西紫杉醇(DTX)疏水药物,用于治疗货物的生物相容性纳米载体。对HCT-116结肠癌细胞系评估了杂交液和NLS的体外毒性。针对巨噬细胞探讨了生物相容性,并在小鼠中检查了急性口腔毒性14天。对于纯多西紫杉醇(DTX),抗癌IC50为0.148μg(-1)与2.38μg(-1)相比。人巨噬细胞活力仍保持在65%以上,并展示了高水平的生物相容性和生物相容性和安全性。体内急性口腔毒性表现出血清生物化学和血液学的轻微变化,但没有观察到DTX加载的杂合体的安全性的显着毒性。关于组织学检查,在肝脏,心脏和肾脏上没有测定病变。这些研究表明,杂交种可以作为用于口服疏水药物的安全和生物相容性平台。

著录项

  • 来源
    《Toxicology Research》 |2017年第6期|共8页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号